Therefore, for the positive control (n = 16) and for the metastatic samples from the biological validation cohort (n = 20 PAAD met.Liv., Additional file 1: Table S6), we correlated the predicted score of the correct class with CD3+ and CD20+ immune infiltrate, tumor purity, and proliferation rate (Ki-67%). This evidence concerns the gene MKI67 and neoplasm.